Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM) Meeting Abstract
| Authors: | Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; Landau, H.; Giralt, S. |
| Abstract Title: | Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM) |
| Meeting Title: | 17th International Myeloma Workshop |
| Keywords: | stem cell transplant; symptom burden; siltuximab |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sep 12-15 |
| Meeting Location: | Boston, MA |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | e299 |
| Language: | English |
| ACCESSION: | WOS:000491229800488 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.clml.2019.09.491 |
| Notes: | Meeting Abstract: SP-165 -- Source: Wos |
